Imatinib Not Yet Recruiting Phase 1 / 2 Trials for Lymphangioleiomyomatosis Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs